Concepedia

Publication | Closed Access

Effects of Teriparatide, Alendronate, or Both on Bone Turnover in Osteoporotic Men

DOI

137

Citations

33

References

2006

Year

Joel S. Finkelstein, Benjamin Z. Leder, Sherri‐Ann M. Burnett‐Bowie, Jason J. Wyland, Hang Lee, Amanda Victoria de la Paz, Kate Gibson, Robert M. Neer
The Journal of Clinical Endocrinology & Metabolism

Abstract

As with BMD, alendronate impairs the action of teriparatide to increase bone turnover in men.

References

YearCitations

Page 1